Introduction
Metabolic acidosis is a common problem in general and intensive care medicine. The anion gap is calculated to differentiate acidosis due to an excess of anions from acidosis due to a loss of bicarbonate. It is determined by calculating the difference between the measured cations, sodium and potassium and the anions, chloride and bicarbonate. The reference range is 8-16 mmol/L. The majority of high anion gap metabolic acidoses are due to accumulation of either lactate or ketones. 1 There are rarer causes however, one of which is the accumulation of 5-oxoproline, which is also known as pyroglutamic acid. The list of causes of high anion gap metabolic acidosis is reviewed in Table 1 .
Paracetamol is a regularly prescribed analgesic and antipyretic due to its low side-effect profile; however it can result in accumulation of 5-oxoproline in individuals who are predisposed to reduced glutathione levels, leading to high anion gap metabolic acidosis. 2 We present two case reports of a high anion gap metabolic acidosis in our intensive care unit (ICU) caused by accumulation of 5-oxoproline.
Case one
A 63-year-old caucasian woman was admitted to the ICU with a nine-day history of lethargy, breathlessness and confusion. Her past medical history included hypertension, hypercholesterolaemia, type two diabetes mellitus, chronic kidney disease stage three, chronic pancreatitis and osteoporosis. Her medications included metformin 500 mg bd atorvastatin 20 mg od, amlodipine 10 mg od, and Creon 10,000 units tds. She had been taking regular tramadol hydrochloride for chronic lower back pain. As her pain was poorly controlled, this had been changed two weeks earlier to
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Accumulation of 5-oxoproline (pyroglutamic acid) has been reported as a rare cause of high anion gap metabolic acidosis. Chronic paracetamol ingestion in a susceptible individual can lead to accumulation of 5-oxoproline and a high anion gap metabolic acidosis. The condition resolves with supportive care and discontinuation of paracetamol and, most importantly, it can be prevented. This case report aims to alert clinicians to the condition as well as provide insight into the underlying mechanisms of the disease process. We report two cases of high anion gap metabolic acidosis due to accumulation of 5-oxoproline. Both patients had a recent history of regular paracetamol use for back pain on a background of poor nutrition. Common causes of high anion gap metabolic acidosis were excluded in both patients systematically. The underlying cause was discovered on testing for urinary 5-oxoproline. Both patients improved and the acidosis resolved upon withdrawal of paracetamol and other supportive measures. The need for a high index of suspicion and a detailed patient drug history is highlighted in these case reports, as raised anion gap metabolic acidosis is a common finding in critically ill patients. When lactate and ketones are absent, 5-oxoproline levels should be tested in patients who are taking paracetamol; especially in those who are malnourished or have other predisposing factors to reduced glutathione levels. Once suspected, paracetamol should be stopped, full supportive care should be initiated and treatment with N-acetylcysteine considered. combined paracetamol 500 mg with codeine 30 mg, two tablets six hourly. She had no known drug allergies and was not taking any other herbal or recreational drugs. She denied alcohol use.
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On examination the patient was cachectic, with a body mass index of 15.2 kg/m 2 . She had a respiratory rate of 32 breaths per minute, pulse rate of 110 beats per minute and blood pressure of 90/50 mm Hg. She was afebrile, drowsy and intermittently confused. Systemic examination was unremarkable.
The patient was profoundly acidotic on arterial blood gas analysis, with pH 7.03, bicarbonate 6.0 mmol/L, base excess −22.6 mmol/L and anion gap of 37 mmol/L. Deranged blood test results included creatinine of 273 μmol/L and urea of 21.8 mmol/L, a normocytic anaemia with haemoglobin of 7.8 g/dL and white cell count mildly elevated at 11.2 ×10 9 /L. Liver function tests were unremarkable. Urine dipstick analysis revealed 'small ketones' (<20 mg/dL) which was not sufficient to explain the anion gap of 37 mmol/L. The patient' s serum lactate level was 1.5 mmol/L. Serum salicylate and paracetamol levels were within reference ranges, and serum ethanol was not detected. Chest X-ray and computed tomography scan of the brain were unremarkable.
The patient was initially treated supportively with IV Hartmann' s solution and piperacillin/tazobactam 4.5 g bd for presumed sepsis; however on day three, she became encephalopathic and required intubation and mechanical ventilation. She subsequently required 24 hours of continuous veno-venous hemodiafiltration for worsening renal failure and persistent acidosis. At this point she received sodium bicarbonate and oral N-acetylcysteine 600 mg bd and paracetamol was stopped. These measures resulted in immediate resolution of her acid-base state.
On day ten of her admission, she was successfully extubated. Results of previously requested investigations revealed that 5-oxoproline had been present in her urine. No ethylene glycol was detected in her blood.
The patient recovered fully and was discharged from the ICU on day 16 of her admission.
Case two
An 83-year-old caucasian woman with a history of hypertension and osteoporosis was admitted to a medical ward with a diagnosis of epidural and paraspinal abscesses with Staphylococcus aureus bacteraemia. She was taking amlodipine 10 mg od and used paracetamol 2 g daily in divided doses for her back pain. She consumed approximately three large glasses of wine per night and was malnourished. Upon admission she was started on intravenous flucloxacillin 2g qds and her paracetamol was increased to 1 g every six hours and on occasions she received intravenous paracetamol.
She subsequently became tachypnoeic and arterial blood sampling revealed a compensated high anion gap metabolic acidosis. She was admitted to ICU on day 25 of her hospital admission with pH 7.39, bicarbonate 9.0 mmol/L, base excess −15.5 mmol/L, pCO 2 1.9 kPa and anion gap of 29 mmol/L. Deranged blood test results included creatinine of 98 μmol/L and potassium of 2.7 mmol/L. Her liver function tests were unremarkable. Her inflammatory markers had improved from admission. There were no ketones detected on urine dipstick analysis and the patient' s serum lactate level was 1.0 mmol/L. Urinary pH was 4.5. Urinary 5-oxoproline levels were raised. This patient was also treated supportively with intravenous fluids and sodium bicarbonate infusion and regular paracetamol was stopped.
Her acidosis improved and within five days her bicarbonate level was within the reference range. She was discharged to the ward where flucloxacillin was continued and her bicarbonate level remained stable.
Discussion
5-oxoproline is an organic acid intermediate of the γ-glutamyl
cycle, which is produced in the synthesis of glutathione. 3 Glutathione is a tripeptide essential for free-radical scavenging and many detoxification reactions including paracetamol metabolism. It irreversibly binds with the paracetomol metabolite N-actetyl-p-benzoquinineimine, making it nontoxic. Glutathione is made up of three amino acids: glutamate, cysteine and glycine. Firstly, glutamate combines with cysteine forming γ-glutamylcysteine via the enzyme γ-glutamylcysteine synthase. Secondly γ-glutamylcysteine joins with glycine with the help of the enzyme glutathione synthase. When there is a deficiency in glutathione there is feedback to increase γglutamylcysteine synthase activity, resulting in surplus γglutamylcysteine. When there is significant glutathione deficiency, far too much γ-glutamylcysteine is produced. Excess γ-glutamylcysteine is converted to 5-oxoproline by γ-glutamyl cyclotransferase. 5-oxoproline can be converted to glutamate by the enzyme 5-oxoprolinase; however, this is a rate-limiting step in the pathway, hence 5-oxoproline accumulates, causing acidosis. Renal dysfunction also reduces the clearance of 5-oxoproline. 4 Sepsis, malnutrition, pregnancy, strict vegan diet, chronic alcohol abuse, impaired liver or kidney function and type two diabetes mellitus have all been reported to result in depletion of glutathione. [3] [4] [5] [6] Chronic paracetamol exposure, even at recommended doses, can further deplete glutathione levels due to accumulation of N-actetyl-p-benzoquinineimine, leading to increased 5-oxoproline concentrations and hence high anion gap metabolic acidosis. Females may be more affected by this problem and although the reason remains uncertain, 7 differences in the activity of isoenzymes of the γ-glutamyl cycle have been postulated.
N-acetylcysteine replenishes glutathione stores in paracetamol overdose by providing cysteine. However, as the excess 5-oxoproline is caused by excess γ-glutamylcysteine it is difficult to see how extra cysteine will help, even if these patients are likely to be also relatively cysteine deficient. Although there have been no studies validating its use in this area, when given orally it is safe and well tolerated 8 and until further information is available it may be considered.
Inherited errors of the γ-glutamyl cycle, including deficiency of glutathione synthase, γ-glutamylcysteine synthase and 5-oxoprolinase are extremely rare and are unlikely in our two case reports.
High anion gap metabolic acidosis occurs frequently in patients with paracetamol overdose, but this is usually due to a combination of lactic acidosis and renal failure 1 rather than 5-oxyoproline accumulation.
In both of our cases, reviewing the patient' s notes, taking a more directed drug history and identifying risk factors for glutathione deficiency were key in reaching a diagnosis. Both patients were complex and had different treatments: the first required haemodiafiltration, which helped clear excess 5-oxoproline, and she also received N-aceytlcysteine; however the second patient did not. Both had been taking paracetamol at the recommended dose; Pitt and Hauser 7 suggest that there is not a dose-response relationship between 5-oxoproline levels and paracetamol dose, and that in overdoses, the levels of 5-oxoproline may even be reduced. The first patient had a previous admission to ICU with a severe high anion gap metabolic acidosis. No cause for the metabolic acidosis had been documented and it resolved once she was changed from paracetamol to tramadol hydrochloride for her back pain. The first patient also had a slight deterioration in her renal function compared to her baseline creatinine. It is possible that this contributed to her acidosis and may have also exacerbated 5-oxoproline excess due to reduced renal clearance. It is unlikely to have been the sole contributing factor to her metabolic acidosis as acidosis associated with renal failure is usually mild and bicarbonate is typically between 12 to 22 mmol/L, only rarely below 12 mmol/L, 9 and the anion gap is rarely higher than 20 mmol/L. 3 The second patient developed an acidosis only when regular paracetamol doses were prescribed. Interestingly, she had been started on IV flucloxacillin at the same time, which has also been implicated in excess 5-oxoproline in prone individuals, 3 where it is thought to reduce 5-oxoprolinase activity. 10 Due to the multiple treatment modalities for the metabolic acidosis in these cases, it is difficult to establish the exact reason for their improvement. In the first case it is likely that haemodiafiltration helped remove 5-oxoproline and cessation of paracetamol and nutritional support helped increase glutathione levels. In the second case, cessation of paracetamol helped increase glutathione levels and bicarbonate helped to neutralise the excess acid. Due to the adverse effects of sodium bicarbonate, 11 this should not be used routinely. Haemodiafiltration may be necessary if persistent acidosis results in organ dysfunction. Due to the relatively few adverse effects of N-acetylcysteine 8 this should be considered in all patients. Nutritional optimisation is mandatory as well as treatment of other complicating factors such as anaemia and sepsis.
Conclusion
Paracetamol is a frequently prescribed medication, which if used chronically in patients who are malnourished, have renal or liver impairment and/or have diabetes mellitus, can contribute to excess 5-oxoproline levels because of reduction in glutathione. As described in our cases, the cause of acidosis can be multi-factorial; however when renal function is not markedly impaired and lactate and ketones are not elevated, excess 5-oxoproline should be considered when risk factors are present, especially in women. Although lactic and keto-acidosis are more common, it is likely that 5-oxoproline is underrepresented due to a low index of suspicion and to the heterogeneous nature of critically ill patients. In addition, in metabolic acidosis when lactate levels are raised, 5-oxoproline may also be a contributing factor in at-risk patients. Diagnosis may also be difficult if analysis for 5-oxoproline is not available. Medical practitioners should be wary of prescribing regular paracetamol in individuals prone to reduced glutathione levels and should consider dose reduction. If this condition is suspected, we recommend ceasing paracetamol, commencing supportive measures and considering initiating empirical oral N-acetylcysteine which may restore glutathione levels. 3, 8 
